The biggest abortion drug company in the United States filed a lawsuit Wednesday in an effort to keep selling its deadly product even if the U.S. Supreme Court blocks the drug’s approval by the FDA.
The lawsuit by GenBioPro, which manufactures the generic version of the abortion drug mifepristone, actually challenges the U.S. Food and Drug Administration, which is fighting a separate lawsuit from pro-life doctors who say the drug is too dangerous and never should have been approved for elective abortions.
It is the third major lawsuit right now involving the FDA’s approval of the abortion drug. The most prominent one comes from a group of doctors with the Alliance for Hippocratic Medicine who argue that the FDA skirted safety regulations when it approved and later expanded mifepristone under Democrat administrations.
The abortion drug now is used for more than half of all abortions in the U.S., killing hundreds of thousands of unborn babies every year.
According to CNN, the new GenBioPro lawsuit claims the FDA violated its constitutional rights in the agency’s response to the pro-life doctors’ case, and the company should be allowed to continue selling the abortion drug even if the Supreme Court upholds a Fifth Circuit Court of Appeals ruling blocking the FDA’s approval.
“With the specter of criminal prosecution looming, GenBioPro may be obligated to undertake recalls, cancel contracted manufacturing and hold or destroy perishable inventory,” the lawsuit states.
SUPPORT LIFENEWS! If you want to help fight abortion, please donate to LifeNews.com!
The company, which is not named in the pro-life doctors’ case, began selling generic mifepristone as an elective abortion drug in the U.S. three years ago. However, the company says it now sells approximately two thirds of all the abortion drugs in the country – meaning it has helped to facilitate hundreds of thousands of unborn babies’ deaths.
According to its lawsuit, its abortion business would suffer “imminent, catastrophic, and irreparable harm” if its blocked from selling mifepristone. In other words, killing unborn babies is big business.
GenBioPro also accuses the FDA of ignoring the “statutory and regulatory procedures” for withdrawing a drug, according to CNN. The lawsuit takes issue with some of the statements the FDA made to the Supreme Court in a recent appeal.
In a filing with the Supreme Court, the FDA says it also believes that under the Fifth Circuit decision, generic mifepristone “would cease to be approved altogether.”
In the new lawsuit, GenBioPro objects to the FDA’s interpretation of that decision and asks a federal court to force the FDA to preserve access. The company says its generic form of the drug accounts for about two-thirds of mifepristone sold in the United States.
The pro-abortion legal group Democracy Forward Foundation is representing the company in the case.
Another abortion company, Danco, which is named along with the FDA in the pro-life doctors’ lawsuit, has been selling the abortion drug in the U.S. since 2000.
The U.S. Supreme Court is expected to rule Friday on a temporary injunction in the pro-life doctors’ case. If the high court sides with the doctors, dangerous mail-order abortions could be prohibited in the U.S. as soon as the end of this week. Other regulations that were in effect for many years also would be reinstated.
In the doctors’ lawsuit, they warn that lives are at risk, and the court must block the dangerous abortion drug. As emergency room physicians and OB-GYNs, the doctors said they have witnessed “the enormous pressure and stress caused by emergency treatment from chemical abortion [abortion drugs] gone wrong.”
First approved under the Clinton administration, mifepristone is used to abort unborn babies up to about 10 weeks of pregnancy – although some abortionists use it later. It works by blocking the hormone progesterone and basically starving the unborn baby to death. Typically, abortion groups also prescribe a second drug, misoprostol, to induce labor and expel the baby’s body.
Studies indicate abortion risks are more common than what abortion activists often claim, with about one in 17 women requiring hospital treatment.
In recent years, abortion drugs have been used for more than half of all abortions in the U.S., killing hundreds of thousands of unborn babies annually, according to the Guttmacher Institute.
Along with millions of unborn babies’ deaths, the FDA has linked mifepristone to at least 28 women’s deaths and 4,000 serious complications. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.
A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.